Willow Biosciences Inc
Atlas Energy Corp., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. The company was formerly known as Willow Biosciences … Read more
Market Cap & Net Worth: Willow Biosciences Inc (CANSF)
Willow Biosciences Inc (OTCQB:CANSF) has a market capitalization of $3.15 Million ($3.15 Million) as of March 18, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #33188 globally and #10847 in its home market, demonstrating a -54.55% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Willow Biosciences Inc's stock price $0.01 by its total outstanding shares 629439354 (629.44 Million).
Willow Biosciences Inc Market Cap History: 2016 to 2025
Willow Biosciences Inc's market capitalization history from 2016 to 2025. Data shows change from $2.52 Million to $3.15 Million (-10.60% CAGR).
Willow Biosciences Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Willow Biosciences Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
8.44x
Willow Biosciences Inc's market cap is 8.44 times its annual revenue
3.43x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $21.34 Million | $16.91K | -$1.64 Million | 1261.63x | N/A |
| 2019 | $307.80 Million | $4.58K | -$44.57 Million | 67145.69x | N/A |
| 2020 | $558.19 Million | $10.00K | -$33.95 Million | 55818.68x | N/A |
| 2021 | $220.93 Million | $133.00K | -$6.14 Million | 1661.15x | N/A |
| 2022 | $50.98 Million | $821.00K | -$14.81 Million | 62.10x | N/A |
| 2023 | $44.06 Million | $1.17 Million | -$13.03 Million | 37.59x | N/A |
| 2024 | $39.34 Million | $4.66 Million | -$6.19 Million | 8.44x | N/A |
Competitor Companies of CANSF by Market Capitalization
Companies near Willow Biosciences Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Willow Biosciences Inc by market ranking:
- Enbridge Inc (NYSE:ENB): Ranked #159 globally with a market cap of $117.74 Billion USD.
- Williams Companies Inc (NYSE:WMB): Ranked #231 globally with a market cap of $88.33 Billion USD.
- The Williams Companies, Inc. (SA:W1MB34): Ranked #286 globally with a market cap of $74.15 Billion USD ( R$451.57 Billion BRL).
- Kinder Morgan Inc (NYSE:KMI): Ranked #340 globally with a market cap of $64.50 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #159 | Enbridge Inc | NYSE:ENB | $117.74 Billion | $54.05 |
| #231 | Williams Companies Inc | NYSE:WMB | $88.33 Billion | $73.69 |
| #286 | The Williams Companies, Inc. | SA:W1MB34 | $74.15 Billion | R$371.65 |
| #340 | Kinder Morgan Inc | NYSE:KMI | $64.50 Billion | $33.27 |
Willow Biosciences Inc Historical Marketcap From 2016 to 2025
Between 2016 and today, Willow Biosciences Inc's market cap moved from $2.52 Million to $ 3.15 Million, with a yearly change of -10.60%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $3.15 Million | -92.00% |
| 2024 | $39.34 Million | -10.71% |
| 2023 | $44.06 Million | -13.58% |
| 2022 | $50.98 Million | -76.92% |
| 2021 | $220.93 Million | -60.42% |
| 2020 | $558.19 Million | +81.35% |
| 2019 | $307.80 Million | +1342.48% |
| 2018 | $21.34 Million | -69.92% |
| 2017 | $70.94 Million | +2717.50% |
| 2016 | $2.52 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Willow Biosciences Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.15 Million USD |
| MoneyControl | $3.15 Million USD |
| MarketWatch | $3.15 Million USD |
| marketcap.company | $3.15 Million USD |
| Reuters | $3.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.